The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP‐BFM ALL protocols
- 25 June 2018
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 182 (5) , 705-711
Abstract
Summary: Notwithstanding the improvement in treatment results for paediatric T cell acute lymphoblastic leukaemia (T‐ALL) it remains important to understand if genetic aberrations influence therapy response. PTEN tumour suppressor gene inactivation is a frequent event in T‐ALL but its effect on patient therapy response is debatable. We analysed the effect of the presence of mutated PTEN on outcome in 257 children with T‐ALL treated with Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)‐Berlin‐Frankfürt‐Münster (BFM) protocols. PTEN mutations were present in 31 (12·1%) patients and were significantly associated with increased risk of relapse. PTEN mutations also indicate a poor prognosis in T‐ALL patients in the absence of NOTCH1 mutations or in the group of patients with co‐presence of PTEN mutation and deletions. These results indicate that PTEN genomic aberrations and the biologically consequential PTEN inactivation contribute to adverse therapy response in T‐ALL patients; PTEN status as a biomarker may contribute to the development of new molecularly‐defined stratification algorithms.Keywords
Funding Information
- Fondazione Città della Speranza
- Associazione Italiana per la Ricerca sul Cancro
This publication has 19 references indexed in Scilit:
- AIEOP‐BFMConsensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic LeukemiaCytometry Part B: Clinical Cytometry, 2017
- The genetics and mechanisms of T cell acute lymphoblastic leukaemiaNature Reviews Cancer, 2016
- Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysisThe Lancet Haematology, 2016
- Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trialLeukemia, 2015
- PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination eventsBlood, 2014
- Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemiaLeukemia, 2013
- NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemiaHaematologica, 2013
- Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemiaLeukemia, 2009
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemiaBlood, 2009
- The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupLeukemia, 2009